Development of SARS-COV therapeutics using quaternary protein mimetics
SARS-CoV, a novel virus belonging to group IV coronavirus, was discovered in association with cases of severe acute respiratory syndrome (SARS) in 2003. The spike (S) protein of SARS-CoV is responsible for receptor binding and membrane fusion. The MPER, the Trp-rich membrane proximal external region...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Theses and Dissertations |
| 語言: | English |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://hdl.handle.net/10356/41875 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|